Trial Profile
[S,S]-Reboxetine add-on trial: a randomized, double-blind, placebo-controlled, multi-center trial of [S,S]-reboxetine in patients with postherpetic neuralgia (PHN) concomitantly treated with pregabalin
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Apr 2022
Price :
$35
*
At a glance
- Drugs Esreboxetine (Primary) ; Pregabalin
- Indications Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Pfizer
- 03 Apr 2022 This trial has been completed in Netherland (End Date: 11 Oct 2007), according to European Clinical Trials Database record.
- 24 Dec 2021 This trial has been completed in Czechia, according to European Clinical Trials Database record.
- 02 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database record.